Trading Companies and Distributors, and Commercial Services and Supplies
SBTI ID
40000120
Localisation
China
Asia
Secteur d'activité
Trading Companies and Distributors, and Commercial Services and Supplies
Type d'organisation
Corporate
Dernière mise à jour
04/12/2025
Statut
Classification
1.5°C
Année cible
2035
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Beijing Keyuan Xinhai Pharmaceutical Business Co., Ltd. commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Beijing Keyuan Xinhai Pharmaceutical Business Co., Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 63.0% by 2035 from a 2024 base year. Beijing Keyuan Xinhai Pharmaceutical Business Co., Ltd. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution and waste generated in operations 37.5% within the same timeframe. Long-Term Targets: Beijing Keyuan Xinhai Pharmaceutical Business Co., Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2024 base year. Beijing Keyuan Xinhai Pharmaceutical Business Co., Ltd. also commits to reduce absolute scope 3 GHG emissions 90.0% within the same timeframe.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques